NEW YORK – March 30, 2023 – Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are feeling the pressure to maintain compliance, minimize risk and safeguard their brand reputation.
Created for by disclosure experts for any professional overseeing the disclosure process in life sciences organizations — disclosure, regulatory affairs, ClinOps and others — Citeline’s new TrialScope Intelligence platform is an all-in-one disclosure solution that centralizes the critical knowledge needed in clinical research for timely compliance with global clinical trial requirements. Citeline’s portfolio of solutions and services covers all aspects of drug development: clinical, regulatory and commercial. TrialScope Intelligence complements Citeline’s flagship regulatory solution, TrialScope Disclose, the industry’s most widely used platform for clinical trial disclosure management.
We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.
Work with us
Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?
We want to hear from you